Precision Microbiome Technology forAcne-Prone Skin: Clinically Validated Barrier Restoration
76% of acne sufferers exhibit impaired skinbarriers due to microbial dysbiosis. At Blue Eyes Biotech, we engineer targetedprebiotic/postbiotic complexes (α-glucan oligosaccharides + Lactobacillusferment lysate) clinically proven to reprogram acne-prone skin ecology:
8-Week Double-Blind RCT Findings(n=102):
- ▲89% ceramide synthesis (LC-MS/MS quantified)
- ▼63% trans-epidermal water loss (TEWL)
- ▼71% inflammatory cytokines (IL-1α/IL-8)
- ▼92% pathogenic C. acnes with ▲15x beneficial S. epidermidis
Mechanism-Driven Advantages:
> Synbiotic Precision:
-α-Glucan oligosaccharides selectively nourish commensal bacteria
-L. ferment lysate boosts antimicrobial peptide production
> Personalization Ready:
-DNA sequencing-based microbiome profiling
-Custom actives blending for genetic/biome subtypes
Supply Chain Excellence:
✅ cGMP/ISO 22716 manufacturing
✅ Strain-specific fermentation (CCTCC No.M2024158)
✅ Stability: 24-month shelf life innitrogen-flushed vials
✅ Formats: Water-soluble liquids (serums),lyophilized powders (creams)
For Brands Developing:
• Medical acneregimens
•Probiotic-infused moisturizers
•Prescription-replacement cosmeceuticals
Request Your Resources:
→ ClinicalStudy Dossier (full biometrics)
→ MicrobiomeCustomization Protocol
→ Free SampleKit (5 formula prototypes)
Contact Our Skin Microbiome Experts:
Email: [email protected]
Explore Technology: www.blueeyes-bio.com